Effects of Angiotensin Receptor/Neprilysin Inhibitor Therapy on NT-proBNP and Cardiac Remodeling in Heart Failure with Reduced Ejection Fraction: Primary Results of the PROVE-HF Study
31 August 2019 (00:00 - 00:00)
Organised by:
About the speaker
Massachusetts General Hospital - Harvard Medical School, Boston (United States of America)
4 More presentations in this session
Doctor E. Shantsila (Liverpool, GB)
Associate Professor M. Zabel (Goettingen, DE)
Access the full session
The Event
ESC Congress 2019
31 August - 4 September 2019
